Review: Invasive management after unstable angina or non--ST- segment elevation Ml does not reduce risk for death or MI: COMMENTARY

Bates, Eric
November 2005
ACP Journal Club;Nov/Dec2005, Vol. 143 Issue 3, p68
Academic Journal
This article comments on a clinical study according to which invasive management after unstable angina or non-ST- segment elevation myocardial infarction (Ml) does not reduce risk for death or MI. The "conservative strategy" limits the use of cardiac catheterization to patients with spontaneous or provokable ischemia, but the term does not convey the fact that 50% of patients allocated to this strategy also received cardiac catheterization. If CABG is required, it should be done electively, if possible. Patients with unstable angina can be considered for either cardiac catheterization or noninvasive stress testing, depending on the clinical assessment of risk.


Related Articles

  • 2008 - Review: Late percutaneous coronary intervention after AMI improves survival more than optimal medical therapy. Brott, Brigitta C.; Hillegass, William B. // ACP Journal Club;7/15/2008, Vol. 149 Issue 1, p5 

    The article presents a study that was conducted by A. Abbate and colleagues on late percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI) improves survival more than optimal medical therapy. The study compared late PCI of the infarct-related artery (IRA) plus medical...

  • Placing COURAGE in Context: Review of the Recent Literature on Managing Stable Coronary Artery Disease. Coylewright, Megan; Blumenthal, Roger S.; Post, Wendy // Mayo Clinic Proceedings;Jul2008, Vol. 83 Issue 7, p799 

    Coronary artery disease (CAD) is the leading cause of death in the United States, but prevention and intervention efforts are lowering mortality. This progress is being undercut by rising rates of obesity and diabetes, and adherence to evidence-based prevention efforts is less than ideal. Many...

  • Benefits and limitations of current antiplatelet therapies. Nappi, Jean // American Journal of Health-System Pharmacy;Jul2008 Supplement, Issue S5, pS5 

    Purpose. The benefits and limitations of current antiplatelet therapies in the management of patients experiencing acute coronary syndrome (ACS) are reviewed. Summary. Antiplatelet agents, including aspirin, thienopyridines, and platelet glycoprotein (GP) IIb/IIIa receptor inhibitors, have...

  • Effects of preoperative magnesium therapy on arrhythmias and myocardial ischemia during off-pump coronary surgery. Beşoğul, Yavuz; Gemalmaz, Hüseyin; Aslan, Recep // Journal of Conservative Dentistry;Jan/Feb2009, Vol. 12 Issue 1, p137 

    BACKGROUND: Heart manipulation during off-pump coronary artery bypass surgery may cause hemodynamic instability, and temporary coronary arterial occlusion may lead to myocardial ischemia. To reduce this, perioperative β-blocking agents or calcium antagonists can be administrated. The effects...

  • Oscillatory functions affecting outcome of coronary heart disease: The hazard of too much or too... Wolf, Stewart // Integrative Physiological & Behavioral Science;Apr-Jun95, Vol. 30 Issue 2, p118 

    Identifies the physiological and behavioral indicators predictive of sudden arrhythmic death in patients who had experienced myocardial infarction in the past. Non-determinants of cardiac mortality; Degree of instability required in the proper physiological balance.

  • Mortality risk higher for MI patients who receive blood transfusions.  // Cardiology Today;Feb2013, Vol. 16 Issue 2, p21 

    The article discusses a study published in the "Archives of Internal Medicine," which found a higher mortality risk among patients with myocardial infarction (MI) who receive blood transfusions.

  • Always look on the bright side…. McCrory, P. // British Journal of Sports Medicine;Feb2007, Vol. 41 Issue 2, p63 

    The author reflects on the increasing number cardiovascular mortality in sports. According to the author, several studies have demonstrated increased cardiovascular mortality with the outcome of local and national football teams. He pointed that mostly is male mortality from myocardial...

  • Serum Chelatable Redox-Active Iron Is an Independent Predictor of Mortality After Myocardial Infarction in Individuals With Diabetes. Sulieman, Mahmoud; Asleh, Rabea; Cabantchik, Zvi I.; Breuer, William; Aronson, Doron; Suleiman, Abeer; Miller-Lotan, Rachel; Hammerman, Haim; Levy, Andrew P. // Diabetes Care;Nov2004, Vol. 27 Issue 11, p2730 

    Presents a study which examined the association of labile plasma iron (LPI) with myocardial infarction and mortality in individuals with diabetes. Blood collection and measurement of LIP; Research design and methodology; Results and discussion; Conclusions.

  • DES show mortality benefit in AMI. Lindsay, Alistair C.; Qureshi, Katie // Heart;Jan2009, Vol. 95 Issue 1, p93 

    The article reports on the study about drug-eluting stents (DES), which shows mortality benefit in acute myocardial infarction (AMI). The study was based on an unselected, population based cohort of 7217 patients undergoing PCI with stenting for AMI over an 18-month period in Massachusetts...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics